These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25247946)

  • 21. Prostatic arterial embolization to treat benign prostatic hyperplasia.
    Pisco JM; Pinheiro LC; Bilhim T; Duarte M; Mendes JR; Oliveira AG
    J Vasc Interv Radiol; 2011 Jan; 22(1):11-9; quiz 20. PubMed ID: 21195898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI.
    Kershaw LE; Hutchinson CE; Buckley DL
    J Magn Reson Imaging; 2009 Mar; 29(3):641-8. PubMed ID: 19243046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostatic Artery Embolization for Benign Prostatic Hyperplasia: Prospective Randomized Trial of 100-300 μm versus 300-500 μm versus 100- to 300-μm + 300- to 500-μm Embospheres.
    Torres D; Costa NV; Pisco J; Pinheiro LC; Oliveira AG; Bilhim T
    J Vasc Interv Radiol; 2019 May; 30(5):638-644. PubMed ID: 31029381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostatic Artery Embolization as an Alternative to Indwelling Bladder Catheterization to Manage Benign Prostatic Hyperplasia in Poor Surgical Candidates.
    Rampoldi A; Barbosa F; Secco S; Migliorisi C; Galfano A; Prestini G; Harward SH; Di Trapani D; Brambillasca PM; Ruggero V; Solcia M; Carnevale FC; Bocciardi AM
    Cardiovasc Intervent Radiol; 2017 Apr; 40(4):530-536. PubMed ID: 28130568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benign prostatic hyperplasia after prostatic arterial embolization in a canine model: A 3T multiparametric MRI and whole-mount step-section pathology correlated longitudinal study.
    Li B; Xu A; Wang N; Min X; Feng Z; Deng M; Li L; Cai J; Kang Z; Jiang K; Kuang D; Wang L
    J Magn Reson Imaging; 2017 Oct; 46(4):1220-1229. PubMed ID: 28182304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate Zonal Volumetry as a Predictor of Clinical Outcomes for Prostate Artery Embolization.
    de Assis AM; Maciel MS; Moreira AM; de Paula Rodrigues VC; Antunes AA; Srougi M; Cerri GG; Carnevale FC
    Cardiovasc Intervent Radiol; 2017 Feb; 40(2):245-251. PubMed ID: 27872986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI.
    Jia G; Heverhagen JT; Henry H; Polzer H; Baudendistel KT; von Tengg-Kobligk H; Levine AL; Rosol TJ; Knopp MV
    Magn Reson Imaging; 2006 Jul; 24(6):721-5. PubMed ID: 16824967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Analysis of Prostate Volume as a Predictor of Outcome in Prostate Artery Embolization.
    Bagla S; Smirniotopoulos JB; Orlando JC; van Breda A; Vadlamudi V
    J Vasc Interv Radiol; 2015 Dec; 26(12):1832-8. PubMed ID: 26428880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of Clinical Outcome after Prostate Artery Embolization with Spherical and Nonspherical Polyvinyl Alcohol Particles in Patients with Benign Prostatic Hyperplasia.
    Bilhim T; Pisco J; Pereira JA; Costa NV; Fernandes L; Campos Pinheiro L; Duarte M; Oliveira AG
    Radiology; 2016 Oct; 281(1):289-300. PubMed ID: 27223621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion-tensor MRI at 3 T: differentiation of central gland prostate cancer from benign prostatic hyperplasia.
    Park SY; Kim CK; Park BK; Ha SY; Kwon GY; Kim B
    AJR Am J Roentgenol; 2014 Mar; 202(3):W254-62. PubMed ID: 24555622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI evaluation of benign prostatic hyperplasia: Correlation with international prostate symptom score.
    Guneyli S; Ward E; Peng Y; Nehal Yousuf A; Trilisky I; Westin C; Antic T; Oto A
    J Magn Reson Imaging; 2017 Mar; 45(3):917-925. PubMed ID: 27487205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR imaging findings of the prostate gland following prostate artery embolization: results from a prospective phase 2 study.
    Ali R; Gabr A; Mouli SK; Kallini JR; Riaz A; Mora R; Lewandowski RJ; Hohlastos E; Casalino DD; Hofer MD; Hamoui N; Miller FH; Hairston J; Salem R
    Abdom Radiol (NY); 2019 Feb; 44(2):713-722. PubMed ID: 30196364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 2, Insights into the Technical Rationale.
    Sun F; Crisóstomo V; Báez-Díaz C; Sánchez FM
    Cardiovasc Intervent Radiol; 2016 Feb; 39(2):161-9. PubMed ID: 26563245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semi-Automatic MRI Feature Assessment in Small- and Medium-Volume Benign Prostatic Hyperplasia after Prostatic Artery Embolization.
    Schmidt VF; Schirren M; Heimer MM; Kazmierczak PM; Cyran CC; Wildgruber M; Seidensticker M; Ricke J; Solyanik O
    Diagnostics (Basel); 2022 Feb; 12(3):. PubMed ID: 35328138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of accessory obturator arteries in prostatic arterial embolization.
    Bilhim T; Pisco J; Pinheiro LC; Rio Tinto H; Fernandes L; Pereira JA
    J Vasc Interv Radiol; 2014 Jun; 25(6):875-9. PubMed ID: 24857944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Histological changes of the prostate and acute urinary retention in patients with benign prostatic hyperplasia].
    Bao QB; He GH; Liu GY; Zhang CG; Yang C
    Zhonghua Nan Ke Xue; 2013 Sep; 19(9):811-4. PubMed ID: 24386860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Nonspherical Polyvinyl Alcohol Particles and Microspheres for Prostatic Arterial Embolization in Patients with Benign Prostatic Hyperplasia.
    Hwang JH; Park SW; Chang IS; Jung SI; Jeon HJ; Lho YS; Kim HG; Paick SH; Park HK
    Biomed Res Int; 2017; 2017():8732351. PubMed ID: 28717651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistive index of prostate capsular arteries: a newly identified parameter to diagnose and assess bladder outlet obstruction in patients with benign prostatic hyperplasia.
    Zhang X; Li G; Wei X; Mo X; Hu L; Zha Y; Hou J
    J Urol; 2012 Sep; 188(3):881-7. PubMed ID: 22819411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphometric analysis of prostate zonal anatomy using magnetic resonance imaging: impact on age-related changes in patients in Japan and the USA.
    Matsugasumi T; Fujihara A; Ushijima S; Kanazawa M; Yamada Y; Shiraishi T; Hongo F; Kamoi K; Okihara K; de Castro Abreu AL; Oishi M; Shin T; Palmer S; Gill IS; Ukimura O
    BJU Int; 2017 Oct; 120(4):497-504. PubMed ID: 28220583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.